Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hikma rolls into Morocco with $158 million Promopharm buy

This article was originally published in Scrip

Executive Summary

Hikma Pharmaceuticals has acquired a majority stake in Promopharm, one of Morocco's leading pharmaceutical groups. Through the acquisition, Hikma will for the first time be able to enter the Moroccan market, which it estimates to be worth around $1.7 billion and set for significant growth as the government aims to expand healthcare coverage from extremely low current levels.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC014704

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel